Author name: Md Sabeeh Ahmad

Md Sabeeh Ahmad is an Analyst at SpicyIP and LLM Candidate at the University of Cambridge. He graduated from the Aligarh Muslim University, Aligarh and has keen interest in Access to Medicines and Health Policy. He can be reached at: [email protected]

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (January 27 – February 2)

/ By / Copyright, Others, Trademark

(This post has been co-authored with SpicyIP Intern Aditi Agrawal and Bharathwaj Ramakrishnan) Here is our recap of last week’s top IP developments including summary of the posts on taking stock of ANI vs OpenAI copyright litigation (Part I and II), and  ‘Machine Unlearning’ and the ANI vs OpenAI case. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week Taking […]

SpicyIP Weekly Review (January 27 – February 2) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (January 20 – January 26)

/ By / Copyright, Others, Patent, Trademark

(This post has been co-authored with SpicyIP Intern Aditi Agrawal) Here is our recap of last week’s top IP developments including summary of the post on the analysis of Delhi HC’s judgment in Master Arnesh Shaw, a letter by MP Haris Beeran to the Government urging to invoke Section 100, Patents Act for rare disease medicine, and the statutory duty under Section 151 of Patents Act. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are

SpicyIP Weekly Review (January 20 – January 26) Read More »

A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine

/ By / Patent

Rajya Sabha MP Haris Beeran wrote to the Minister of Health and Family Welfare on December 20, 2024, urging the Central Government to invoke Section 100 (1) of the Patents Act with respect to local production of the rare disease Spinal Muscular Atrophy (SMA) treating drug Risdiplam. SMA is a genetic disease affecting the nerve cells that control voluntary muscle movement. SMA incidence in India is one in 10,000 live-born babies. Section 100 empowers the central government to use, or

A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (January 13 – January 19)

/ By / Copyright, Others, Patent, Trade Secret, Trademark

Here is our recap of last week’s top IP developments including summary of the post on the analysis of Cigma Events Private Limited v. Deepak Gupta & Ors and enforcing criminal remedies against IP infringement in India. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week Trust Issues – When Secrets Come with a Commercial Price: Analyzing Cigma Events Private

SpicyIP Weekly Review (January 13 – January 19) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (January 6 – January 12)

/ By / Copyright, Others, Patent, Trademark

Here is our recap of last week’s top IP developments including summaries of the posts on Lemley’s and Henderson’s paper on AI Terms of Use Restrictions, CGPDTM order on the removal of a patent agent, Delhi HC order on disclosure of a PhD and Public Interest Need in Personality Rights cases. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week

SpicyIP Weekly Review (January 6 – January 12) Read More »

Committee Recommends Deregistration of Patent Agent After Professional Misconduct Allegations

/ By / Others, Patent

The CGPDTM has ordered the removal of a patent agent from the Register of Patent Agents following a recommendation by the Ad-Hoc committee that had been constituted by the DPIIT to deal with the complaints against Patent or Trademark Agents. Readers will recall that back in September 2024, the CGPDTM had formed two committees following the Delhi HC’s directions in Saurav Chaudhary v. Union of India & Anr. Interestingly, the agent in this case was the one involved in Saurav

Committee Recommends Deregistration of Patent Agent After Professional Misconduct Allegations Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (December 30 – January 5)

/ By / Copyright, Others, Patent, Trade Secret, Trademark

Here is our recap of last week’s top IP developments including summaries of the posts on India’s Top IP Developments in 2024, a potential trade secret litigation at the Delhi HC and Screenwriters Rights Association of India’s registration as Copyright Society. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week A Look Back at India’s Top IP Developments of 2024

SpicyIP Weekly Review (December 30 – January 5) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (December 23 – December 29)

/ By / Copyright, Others, Patent, Privacy, Trademark

Here is our recap of last week’s top IP developments including summaries of the posts on Delhi HC’s ruling on Celebrity Rights and the Powers of Regional Directors under Companies Act vis a vis Trademark Similarity. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week Delhi High Court Rulings on Celebrity Rights Galore: Examining the Rajat Sharma and Mohan Babu

SpicyIP Weekly Review (December 23 – December 29) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (December 16 – December 22)

/ By / Others, Patent, Trademark

Here is our recap of last week’s top IP developments including summaries of the posts on formulation/composition claims and Section 3(d), Managing IP’s Most Influential People in IP List, and Médecins Sans Frontières (MSF) suit against Dharma Production. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week Formulation/Composition Claims and Section 3(d): Analyzing the Utidelone Pre-grant Opposition Order In light

SpicyIP Weekly Review (December 16 – December 22) Read More »

SpicyIP Tidbit: Médecins Sans Frontières suit against Dharma Productions for Jigra scene

/ By / Trademark

In an interesting development that caught my eye (coincidentally after reading Shravya’s post here on Mediation in IP), Médecins Sans Frontières (MSF) has filed a suit against Dharma Production for using the MSF trademark in a scene of the movie Jigra. MSF, commonly also known as Doctors without Borders, is involved in humanitarian medical care and has long been an advocate for ‘access to medicines’. Interestingly, in October this year Adar Poonawalla (CEO of the Serum Institute of India) acquired

SpicyIP Tidbit: Médecins Sans Frontières suit against Dharma Productions for Jigra scene Read More »

Scroll to Top